A TEAM of researchers from the Eijkman Institute for Molecular Biology was already on its way to developing a vaccine soon after the Covid-19 pandemic struck Indonesia. They had finished the vaccine development concept by the end of March but, alas, they ran into a major obstacle in the execution of the plan. “The time needed to procure reagents and the media to breed virus stretched from a week to a month,” David Handojo Muljono, a s